JODY BARHAM: Open Payments
NPI 1992081491 · TEXARKANA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 5 payments from 4 companies in 2025. Trend: 2023 $495 · 2024 $99 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 2 | $94 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: Qelbree, HETLIOZ, Quviviq, REXULTI.
Industry payments across AR — which companies pay providers there.
